ObvioHealth to collect data for virtual Covid-19 registry study after app gets clearance
The company launched the study to collect data on Covid-19 symptoms and immune responses earlier this month. The goal is to recruit 10,000 participants and then follow them for six months. Participants developing symptoms will be eligible for serological testing.